Shares of Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.13 and traded as high as $0.22. Enzon Pharmaceuticals shares last traded at $0.20, with a volume of 94,897 shares trading hands.
Enzon Pharmaceuticals Stock Up 11.0 %
The business has a 50-day simple moving average of $0.11 and a two-hundred day simple moving average of $0.13. The stock has a market capitalization of $14.84 million, a P/E ratio of 20.02 and a beta of 0.49.
About Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Featured Stories
- Five stocks we like better than Enzon Pharmaceuticals
- How to Evaluate a Stock Before BuyingÂ
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- Differences Between Momentum Investing and Long Term Investing
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Quiet Period Expirations Explained
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
